MedCity News June 13, 2024
The Supreme Court sided with the FDA and unanimously ruled to uphold access to abortion pill mifepristone. The decision quells worries about what it might look like if the Supreme Court sided with the physician group — many healthcare leaders feared that if the top court could overturn mifepristone’s FDA approval, the same could happen to other drugs.
The U.S. Supreme Court sided with the FDA on Thursday morning, unanimously ruling to uphold access to the abortion pill mifepristone. The case’s plaintiff — the Alliance for Hippocratic Medicine, an anti-abortion physician group — had been challenging mifepristone access ever since the drug was approved by the FDA nearly 25 years ago.
The long-awaited decision quells the anxiety of many in...
Today's Sponsors
Today's Sponsor